MECHANISMS OF ACTIVATION OF HEMATOPOIETIC RECOVERY DUE TO FILGASTRIM IN BREAST CANCER PATIENTS RECEIVING CHEMOTHERAPY WITH DOXORUBICIN/DOCETAXEL

The effect of recombinant human granulocyte colony-stimulating factor (filgrastim) on hematopoietic recovery was studied. The study included 77 patients with stage III–IV breast cancer who received chemotherapy with oxorubicin/docetaxel. Filgastrim was administered to 30 patients in the intervals be...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Т. Yu. Khrichkova, V. Е. Goldberg, N. О. Popova, Е. I. Simolina, Yu. V. Belevich, V. V. Zhdanov, L. А. Miroshnichenko, Е. V. Udut, Е. V. Simanina
Format: Artigo
Idioma:Russo
Publicat: Tomsk National Research Medical Center of the Russian Academy of Sciences 2016-02-01
Col·lecció:Sibirskij Onkologičeskij Žurnal
Matèries:
breast cancer, chemotherapy, granulocytopoiesis, docetaxel, filgastrim
Accés en línia:https://www.siboncoj.ru/jour/article/view/201
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars